Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Change in Cash: 2016-2024

Historic Change in Cash for Monopar Therapeutics (MNPR) over the last 9 years, with Dec 2024 value amounting to $38.6 million.

  • Monopar Therapeutics' Change in Cash rose 955.75% to $5.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $13.5 million, marking a year-over-year increase of 531.80%. This contributed to the annual value of $38.6 million for FY2024, which is 4289.72% up from last year.
  • Per Monopar Therapeutics' latest filing, its Change in Cash stood at $38.6 million for FY2024, which was up 4,289.72% from -$920,114 recorded in FY2023.
  • Monopar Therapeutics' Change in Cash's 5-year high stood at $38.6 million during FY2024, with a 5-year trough of -$12.1 million in FY2022.
  • Its 3-year average for Change in Cash is $8.5 million, with a median of -$920,114 in 2023.
  • Per our database at Business Quant, Monopar Therapeutics' Change in Cash crashed by 439.74% in 2022 and then surged by 4,289.72% in 2024.
  • Monopar Therapeutics' Change in Cash (Yearly) stood at $3.5 million in 2020, then grew by 1.24% to $3.6 million in 2021, then tumbled by 439.74% to -$12.1 million in 2022, then skyrocketed by 92.41% to -$920,114 in 2023, then soared by 4,289.72% to $38.6 million in 2024.